C/EBP Beta Polyclonal Antibody

CEBPB (CCAAT/Enhancer Binding Protein Beta) is a Protein Coding gene. Diseases associated with CEBPB includeShort-Rib Thoracic Dysplasia 1 With Or Without PolydactylyandShort-Rib Thoracic Dysplasia 2 With Or Without Polydactyly. Among its related pathways areTranscription factor regulation in adipogenesisand Folate-Alcohol and Cancer Pathway.

The C/EBP Beta Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CCAAT/enhancer binding protein beta (C/EBP Beta) in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity.

C/EBP Beta is a transcription factor that plays a crucial role in the regulation of gene expression, particularly in the context of cellular differentiation and inflammation. It is involved in various physiological processes, including adipogenesis, liver regeneration, and immune response. The C/EBP Beta Polyclonal Antibody recognizes the endogenous levels of C/EBP Beta, enabling accurate quantification and localization studies.

This antibody has been extensively validated for its specificity and performance in multiple applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other related proteins, ensuring reliable and accurate results. The C/EBP Beta Polyclonal Antibody is suitable for use in both research and clinical settings, facilitating a wide range of investigations in the field of molecular biology and biomedical research.

With its high quality and consistent performance, the C/EBP Beta Polyclonal Antibody is an indispensable tool for scientists and researchers studying the intricate mechanisms of gene regulation and cellular processes. Its exceptional sensitivity and specificity make it an ideal choice for those seeking reliable and reproducible results in their experiments.